chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got a hard pimple on middle knuckle that itches and hurts to the touch,Then another one developed on my index finger towards thumb; Itches and hurts to the touch.; Itches and hurts to the touch.; Soreness on ring finger on the pinky side; Then something hard developed that turned dark red; Swelling; Similar to a boil and the size of a pencil eraser; This spontaneous case was reported by a consumer and describes the occurrence of FURUNCLE (Similar to a boil and the size of a pencil eraser), ACNE (Got a hard pimple on middle knuckle that itches and hurts to the touch,Then another one developed on my index finger towards thumb), PRURITUS (Itches and hurts to the touch.), PAIN IN EXTREMITY (Itches and hurts to the touch.) and PAIN (Soreness on ring finger on the pinky side) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced FURUNCLE (Similar to a boil and the size of a pencil eraser), PAIN (Soreness on ring finger on the pinky side), INDURATION (Then something hard developed that turned dark red) and SWELLING (Swelling). On 15-Mar-2021, the patient experienced ACNE (Got a hard pimple on middle knuckle that itches and hurts to the touch,Then another one developed on my index finger towards thumb), PRURITUS (Itches and hurts to the touch.) and PAIN IN EXTREMITY (Itches and hurts to the touch.). At the time of the report, FURUNCLE (Similar to a boil and the size of a pencil eraser), ACNE (Got a hard pimple on middle knuckle that itches and hurts to the touch,Then another one developed on my index finger towards thumb), PRURITUS (Itches and hurts to the touch.), PAIN IN EXTREMITY (Itches and hurts to the touch.), PAIN (Soreness on ring finger on the pinky side), INDURATION (Then something hard developed that turned dark red) and SWELLING (Swelling) outcome was unknown.            Concomitant medications were not provided.  Treatment medications were not provided by the reporter.
numbness on forehead, progressed to painful red pustules on forehead and scalp - Shingles
VACCINE L ARM @0732. DURING CHECK OUT, AFTER 15 MINUTES, REPORTED RACING HEART, "HEAD WOOZY", AND FATIGUE. ON EXAM, SOME SLURRING OF SPEACH AND EYES CLOSED- IMPROVED AFTER 10 MINUTES. MEDS: CYMBALTA, CELEBREX, ZYRTEC, MINIPRES. MINITORED ADDITIONAL 30 MINS. WALKING, TRANSFERRED TO STRETCHER WITHOUT DIFFICULTY. RELEASED AT 0830.
Fever 103.6. Rash face, arms, legs, trunk. Sore leg - limp. Refuses to bear weight.
approximately a couple of weeks after the vaccine in left arm I began having pain in left knee and left hip. I normally have some level of pain, I assume from arthritis but this was extreme and lasted until beginning of August. For the first few weeks my knee felt as if it was needing to crack but it did not. After a few weeks, it did crack and then started locking each time I got up and needed to straighten the knee. I waited two months to see if it would get better and it did not so went to doctor. I had MRI and x ray. No torn meniscus and said my cartilage was fine. It did start to improve on its own over time at the same time the hip pain also lessened. After 4 months, there knee has stopped locking and the hip and knee have no more pain. There was no other explanation such as injury to explain this incident.
Allergic reaction broke out in hives on my back then hours later had a swollen lip reaction this has never happened to me before prior to the vaccination
Rapid came back positive for covid; Achiness got worse; This is a spontaneous report from a contactable other hcp Nurse (patient).  A patient of an unspecified age and gender received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number: not reported), dose 1 via an unspecified route of administration on 27Apr2021 09:30 as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included achiness. The patient's concomitant medications were not reported. On 27Apr2021 13:00, the patient experienced achiness got worse; On 28Apr2021 13:00, had a fever and had a 101 temperature; 14:30 rapid came back positive for COVID and 14:30 patient was just not feeling good. The patient underwent lab tests and procedures which included body temperature: 101 centigrade on 27Apr2021, polymerase chain reaction: positive on 27Apr2021, sars-cov-2 test positive: positive on 27Apr2021. It was reported that patient was not feeling good. The patient just wanted to call to make sure that the patient has COVID and got a vaccine, and it was not a problem. The patient had COVID and at night was feeling some achiness, but thought it was from exercising that patient was doing and then after had the vaccine that was 1 o'clock had a fever. So, was thinking if the patient did not have that achiness, the patient just wanted to go get tested just to be sure because the patient did not want to walk around. The patient finds it odd from first vaccine to be getting any kind of symptoms like that so had a 101 temperature and the achiness got worse. So, the patient went and had a test at 2:30 and had a rapid and a PCR and the rapid came back positive for COVID. The patient wants to know was there any concerns that should have having the vaccine while the patient was positive for COVID. The outcome of all the events was unknown.  No Follow-up attempts are needed. Information about lot/batch cannot be obtained.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 04-AUG-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # K025766, expiry date 08-JUN-2015. This is one of the several reports received from the same reporter. Additional information has been requested.
4-6 10 Pm: hives on R&L forearms nausea Injection site itchy 4-7-10: Injection site painful, raised ~ 3" red 4-8-10: Injection site hard, raised ~ 3"; painful. Increased pruritis.
cough & T onset 1 hr /p vax. T up to 104, vomiting X several hrs, T lasted days, saw MD 5Dec. Throat red, enlarged anterior nodes, cough, T noted in chart. MD states UNK whether T & other illness symptoms related to vax. Recommends DT.
Migraine type headache, Muscle aches, Fever 102, severe stomach pain.
Patient called in the morning on 10/25/18 and said starting last night he felt unwell. He described his symptoms as achy, having nausea and dizziness that makes it difficult to stand. He went to work and found he was very dizzy and called the pharmacy. I asked if he felt like he should be seen by a doctor he said not at this time.
24/7 Migraine - lasted approximately 10 days, did not improve with Advil  Nausea - lasted approximately 10 days, came in strong waves, usually strongest when the migraine was at its worst Chills/Cold Sweats - lasted approximately 24 hours  Fatigue - lasted about a week Rapid Heart Beat - occurred sporadically for about a week
The infant was non consolable for 73 hrs, status post Acell-DPT, IPV, and Comvax (Hep B & Hib).
Started having tremors inside my body, some palpitations. Having had many work ups over the year. Diag: Essential tremor of unknown orgin. Has there been anything like this reported?
swollen lymph node in my left arm pit that was red and  tender to the touch.  Swelling and tenderness disappeared in approximately 25  days.  Dr viewed  it on April 13th  & confirmed  it was a swollen  lymph node
pt recv vax & 6hr p/vax pt exp redness, swelling, fever (unspecified) & fussiness;
The vial was initially stored in the refrigerator on 25SEP2022 and administered on 28OCT2022; No adverse event; Moderna bivalent administered after 30 day beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25SEP2022 and administered on 28OCT2022) and NO ADVERSE EVENT (No adverse event) in an 88-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 28-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25SEP2022 and administered on 28OCT2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25SEP2022 and administered on 28OCT2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25SEP2022 and administered on 28OCT2022).    No concomitant medication were reported.  The Moderna COVID-19 bivalent booster dose were administered after a beyond use date of 25-OCT-2022. Unbroken carton with unknown vial size. The vial was initially stored in the refrigerator on 25-SEP-2022. The vial did not undergo any temperature excursions.  No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-667362 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-667362:male patient
12/4/21  46-year-old white male multiple medical problems reviewed former smoker with multiple drug allergies noted including sulfa and penicillin allergy comes to clinic complaining of ongoing cough he is Covid vaccinated continue to work in the public he is vaccinated for Covid still having nonproductive cough no shortness of breath he has history of asthma uses nebulizer at home multiple medications multiple drug allergies noted does not smoke
Three months after getting 4th dose of Pfizer, developed COVID-19. Took home test. Breakthrough.
1/8/02 seen with reaction locally; swelling and erythema left thigh 4cmx8cm. No fever. Completely resolved in 5 days.
Patient 20 minutes after shot administration started to itch from head to knees. They were negative for hives or redness. The patient was also negative for difficulty of breathing. The patient only had itching, and went to the walk in clinic across the street after we gave the shot here at our store. She then received oral prednisone to treat the itching, and it helped. The patient is okay. This was the Spikevax Vaccine that was released in September.
She said that she also experienced leg cramps and fever last night but it also started before she had the vaccine; She said that she also experienced leg cramps and fever last night but it also started before she had the vaccine; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced leg cramps and fever last night but it also started before she had the vaccine. Outcome of the event was unknown, at the time of this report. No follow-up attempts are possible; information about lot/batch cannot be obtained.
arms are killing; feel mildly headachy; tired; Initial information received on 26-Oct-2021 regarding an unsolicited valid Social Media non-serious case from a consumer/non-health care professional.  This case involves a patient (unknown age and gender) whose arms are killing (limb discomfort), feel mildly headachy (headache) and tired (fatigue) after receiving INFLUENZA VACCINE.  Concomitant medication included unknown Pfizer booster.  The patient's medical treatment(s) and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious events "arms are killing" (limb discomfort), feel mildly headachy (headache) and tired (fatigue) (unknown latency) following the administration of vaccine.  It was unknown if the patient experienced any additional symptoms/events.   No laboratory data reported.  It was reported "Got my Pfizer booster (& my flu shot) yesterday. Arms are killing me, feel mildly headachy/tired, but mostly just grateful to be benefiting from science in such a positive way."   It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was unknown for the events.  There will be no information on the batch number for this case.
COVID Arm - day six from first vaccine application.  Itchy rash around injection site.
Rash; This case was reported by a consumer and described the occurrence of rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 12 days after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The patient developed rash 12 days after the 1st vaccine. The patient enquired whether the vaccine was failed, and should he/she receive 2nd dose of vaccine. The reporter did not give permission to follow up.
Patient stated she started feeling nauseous right after the vaccine.  Within the hour, she started having stabbing abdominal pain.  This lasted about 2 days.  Nausea lasted about 4 days.  She also stated she started having muscle spasms in her calves that are still ongoing.  Not known if the spasms are related to the vaccine, but they started around the same time.
20 minutes after vaccine. She reported blurred vision, a feeling of "not feeling right", nausea, chest tightness, tingling of lips and tongue feeling "thick". Patient was nurse working at a Long Term Care center. After symptoms started pt. was transferred to the Emergency Dept. were she received oxygen, aerosol treatments, medication for symptoms.
Pt felt dizzy, had mild difficulty breathing, and felt mildly confused for a few hours following getting her first Pfizer COVID19 vaccine on 4/13/21. Symptoms started within two hours. Pt is pregnant, as well.  Pt scheduled for c-section on 6/18/2021 (reported EDC 6/23/21)  G2P1.  Message sent to PCP for clearance on reported s/s
General muscle aches noticeable around 4pm getting progressively more severe until the point of extreme cramping in her lower back, around her previous injury and in line with her chronic back pain. Muscle spasm occurred from 8:40pm until 9:05pm when she agreed to go to the ER. Pain was 10 out of 10 for approximately an hour until medical intervention. Flexeril injection into lower back. 5% lidocaine patch applied. Cyclobenzeprine tablet ingested. Pain was managed and patient was released around 11:15. Oral prednisone prescribed along with oral cyclobenzeprine. Following day showed major reduction in acute pain but muscles are very sore from prolonged constriction.
HEADACHE, FATIGUE, NEXT DAY SWELLING AND OOZY.
This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 02-MAY-2016, the patient was vaccinated with an improperly stored dose of VARIVAX injection, lot #L034372, expiration date 08-SEP-2017 (dose and route were not reported). Concomitant therapies were not provided. According to the reporter, the vaccine was stored at a temperature of 17 degrees Fahrenheit for 52 minutes and 30 seconds. There were no previous temperature excursion reported. No adverse effect was reported. No product quality complain (PQC) was involved. It was also reported that the vaccines ZOSTAVAX, PROQUAD, M-M-R II were also improperly stored, however, those vaccines were not administered to patients. This is one of two reports received from the same reporter. Additional information has been requested.
3 hours later after immunization had episode of paleness and very tired, chills, cold to touch, than became lethargic, blue lips.
SYNCOPE, HYPOTENSION, NUMBNESS IN ARM OPPOSITE INJECTION SITE.  MONITORED BY CNP AND EMS CALLED BUT NOT TRANSPORTED
A week after I received first shot arm swelled,  became itchy, hot to touch, and began to hurt a bit again.
Intense shoulder pain, tried Ibuprofen, and heating pad, which then caused a severe rash.
Swelling at injection site, fatigue, nausea, chills, hot flashes, mental fog, upset stomach and trouble with appetite for 2-3 days.
Patients arm is achy from the should down through the finger tips of the left arm, up to the base of her head and spreads to her shoulder blade. All of this is to the left of her spine on the side the shot was administered.; Patients arm is achy from the should down through the finger tips of the left arm, up to the base of her head and spreads to her shoulder blade. All of this is to the left of her spine on the side the shot was administered.; Patients arm is achy from the should down through the finger tips of the left arm, up to the base of her head and spreads to her shoulder blade. All of this is to the left of her spine on the side the shot was administered.; This is a spontaneous report from a contactable consumer. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Information on other medical history and known allergies was not available. Concomitant medications taken within two weeks of vaccination included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), levothyroxine sodium (SYNTHROID), vitamin d nos (VITAMIN D), Bariatric Vitamin and biotin (MANUFACTURER UNKNOWN); all from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 13:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 07:30, the patients arm was achy from the should down through the finger tips of the left arm, up to the base of her head and spread to her shoulder blade. All of this was to the left of her spine on the side the shot was administered. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events arm was achy from the should down through the finger tips of the left arm, up to the base of head and spread to shoulder blade was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
administration to an underage patient; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old male patient who received DTPa-IPV (Kinrix) (batch number E2L54, expiry date 3rd March 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 19th January 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 19th January 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received Kinrix at the age of 3 years, which led to inappropriate age at vaccine administration. The reporter consented to follow up.  The Vaccine Administration Facility is the same as Primary Reporter.
Blood Pressure increased to  185/105 Doctor had to increase Losartin and add additional  blood pressure medicine
p/vax pt devel tingling, numbness of tongue & lips. also devel dizziness & ataxic gait
1 hr after vaccine - blothiness and redness all over body, feet swollen, legs swollen, questionable knee swelling. Legs felt heavy/wobbly leg pain/joint pain and swelling.
On or about January 30, 2021 pain started inside my upper thighs, after about 24 hrs the pain moved to my groin. I contacted my Primary Care Physician and  he instructed me to take 2 Aleve twice a day for 3 days. After completing the aleve for 3 days the pain went away. At this time I have a mild pain inside my upper right thigh.
c/o  nausea also swelling in lat arm upper deltoid muscle, sl redness, very hot to touch;pt saw MD 23SEP96 who labelled serum sickness;
I had a knot in my arm for about 2 and a half weeks after the first dose.; The knot was red, warm, and itchy for most of that time; My underarms were also very itchy with no visible signs of irritation/itchy for most of that time; The knot was red, warm, and itchy for most of that time; This is a spontaneous report from Non-contactable consumer (patient). A 41-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was unknown) via an unspecified route of administration, administered in Arm Left on 12Sep2021 (41-year-old at the time of vaccination) as dose 1, single for covid-19 immunisation. Medical history included allergy from an unknown date and unknown if ongoing. The concomitant medications were reported as none. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Sep2021 05:00, the patient experienced knot in my arm for about 2 and a half weeks after the first dose, the knot was red, warm, and itchy for most of that time, underarms were also very itchy with no visible signs of irritation/itchy for most of that time. The patient received no treatment for the events. Patient was not hospitalised for the events. The outcome of the events was recovering.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.